Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CRT-D May Reap Higher CE Ratio Than Defibrillation Alone – Annals Editorial

This article was originally published in The Gray Sheet

Executive Summary

Implantable cardioverter defibrillators with resynchronization (CRT-D) are likely to prove more cost-effective than ICD therapy alone for patients with moderate-to-severe heart failure, according to Stephen Pauker, MD, et al., Tufts University

You may also be interested in...



CRT-D Cost-Effectiveness Disputed; JACC Editorial Says More Studies Needed

Additional head-to-head trials are necessary to assess whether the benefit of cardiac resynchronization therapy with defibrillation (CRT-D) justifies its high cost, according to Mark Hlatky, MD, Stanford University

CRT-D Cost-Effectiveness Disputed; JACC Editorial Says More Studies Needed

Additional head-to-head trials are necessary to assess whether the benefit of cardiac resynchronization therapy with defibrillation (CRT-D) justifies its high cost, according to Mark Hlatky, MD, Stanford University

CRT-P Versus CRT-D: A Match-Up Likely Never To Be Seen – NEJM Editoral

Cardiac resynchronization with cardioverter defibrillation devices (CRT-D) will continue to be used more often than CRT-alone, even though the latter option may actually be better for some heart failure patients, according to John Jarcho, MD, Brigham & Women's Hospital, Boston

Related Content

UsernamePublicRestriction

Register

MT021977

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel